Harrow, Inc. (HROW)
36.35
+0.18
(+0.50%)
USD |
NASDAQ |
Mar 06, 16:00
36.46
+0.11
(+0.30%)
After-Hours: 20:00
Harrow SG&A Expense (TTM) : 109.60M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 448.72M |
| Esperion Therapeutics, Inc. | 161.28M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Theravance Biopharma, Inc. | 75.94M |
| Rhythm Pharmaceuticals, Inc. | 194.94M |